Gene Query: ASF1A

Dataset Description Geneva Score
Cleavage Factor Im as a key regulator of 3’ UTR length 28.92
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 22.15
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 21.65
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 21.5
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 21.09
WRN knockout effects upon gene expression in SW48 and OVK18 20.45
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 20.41
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 18.56
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 17.64
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 17.64
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 17.26
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 17.26
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 16.45
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 16.45
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 14.02
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 14.01
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 13.92
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 13.84
Seletive inhibition of CDK9 in DLBCL cell lines 13.16
Comprehensive comparative analysis of 5’ end RNA sequencing methods 12.66
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 12.32
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 11.75
Genetic-to-epigenetic Therapy for Pancreatic Cancer 11.72
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 11.09
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 11.07
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 10.94
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 10.94
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 10.83
DART-seq: an antibody-free method for global m6A detection 10.78
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 10.46
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 10.45
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 10.41
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 10.38
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 10.13
Hypoxic transcriptome of SQ20B human head and neck cancer cells 9.97
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 9.94
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 9.88
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 9.84
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 9.79
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 9.42
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 9.32
Oncogenic MYC induces a dependency on the spliceosome in human cancer 9.22
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 9.17
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 9.08
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 9.08
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 9.03
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 8.96
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 8.91
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 8.86
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 8.59
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 8.55
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 8.55
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 8.4
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 8.35
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 8.19
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 8.17
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 8.14
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 8.05
Hepatitis C virus functionally sequesters miR-122 8.05
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 8.05
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 7.96
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 7.94
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 7.93
Total RNA-seq in ALL-SIL upon TLX1 knockdown 7.92
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 7.92
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 7.88
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 7.84
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 7.79
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 7.74
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 7.62
Genome wide miR-191 target profile determined by RIP and gene expression profiling 7.45
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 7.45
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 7.41
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 7.41
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 7.4
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 7.4
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 7.27
Gene expression signatures of innate lymphoid cells from human blood 7.23
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 7.22
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 7.22
Effect of PRDM11 depletion in U2932 cells 7.22
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 7.18
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 7.18
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 7.17
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 7.08
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 7.06
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 6.98
Pharmacologic inhibition of STAT5 in AML 6.96
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 6.94
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 6.94
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 6.94
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 6.86
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 6.65
scRNASeq analysis of cycling cardiomyocytes 6.63
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 6.6
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 6.51
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 6.42
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 6.39
CROP-Seq in Primary Human T Cells 6.37
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 6.31
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 6.26
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 6.23
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 6.21
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 6.2
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 6.18
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 6.12
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 6.11
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 6.08
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 5.96
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 5.93
Maturation of human iNSCs 5.81
Transcriptome-wide identification of CELF2 functional targets in T cells 5.81
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 5.73
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 5.72
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 5.66
Spliceosomal disruption of the non-canonical BAF complex in cancer 5.65
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 5.65
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 5.59
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 5.54
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 5.53
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 5.5
Identification of Nrf2 regulated genes by RNA sequencing 5.47
Nrf2 regulated genes in A549 cells 5.47
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 5.42
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 5.37
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 5.22
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 5.16
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 5.12
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 5.12
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 5.1
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 5.07
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 5.05
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 4.97
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 4.94
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 4.91
Silencing p300 in MCF7 cells to study expression and alternative splicing 4.89
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.85
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 4.85
In vitro modeling of human germ cell development using pluripotent stem cells 4.83
Transcriptional profile in human S. haematobium infection 4.81
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 4.8
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 4.8
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 4.79
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 4.79
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 4.79
MAIT cell RNA sequencing 4.74
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 4.71
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 4.7
A role for ZNF598 in post-transcriptional gene regulation 4.68
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 4.67
RNAseq analysis of ESRP regulated splicing events in prostate cancer 4.62
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 4.62
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 4.62
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 4.58
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 4.56
RNA expression analysis upon JMJD1C depletion 4.56
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 4.56
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 4.56
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 4.56
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 4.53
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 4.51
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 4.5
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 4.49
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 4.45
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 4.42
Integrating single-cell transcriptomic data across different conditions, technologies, and species 4.41
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 4.4
Dynamic 3D chromosomal landscapes in acute leukemia 4.4
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 4.37
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.37
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 4.36
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 4.36
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 4.33
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 4.33
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 4.32
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 4.27
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 4.26
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 4.25
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 4.25
A Unique Epigenomic Landscape Defines Human Erythropoiesis 4.25
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 4.21
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 4.18
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 4.18
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 4.18
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 4.18
LncRNA expression profiling of ischemic stroke patients 4.17
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 4.16
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 4.16
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 4.14
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 4.14
Mechanistic Model-Guided Study of Embryonic Morphogenesis 4.12
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 4.11
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 4.11
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 4.11
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 4.11
Regulation of protein translation during mitosis 4.1
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 4.09
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 4.09
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 4.09
The Genetic Landscape of Diamond-Blackfan Anemia 4.07
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 4.06
Genome wide expression change in LCC2 and MCF-7 cells 4.05
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 4.05
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 4.05
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 4.04
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 4.01
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 4.0
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 3.98
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 3.97
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 3.95
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 3.94
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 3.94
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 3.92
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 3.92
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 3.92
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 3.91
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 3.91
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 3.9
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 3.89
RNAseq Study in CC-671 Treated Cal-51 Cells 3.89
Transcriptome of U251 cells overexpression complement component 7 3.89
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 3.85
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 3.85
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 3.83
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 3.82
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 3.82
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 3.81
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 3.79
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 3.79
HNRNPL and its RNA Targets in Prostate Cancer 3.79
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 3.78
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 3.78
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 3.78
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 3.78
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 3.77
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 3.76
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 3.75
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 3.75
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 3.74
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 3.73
Primate transcript and protein expression levels evolve under compensatory selection pressures 3.73
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 3.71
Single-cell analysis of adult human ovary using 10X genomics 3.7
Analysis of transcriptional regulation by Myt1 and Myt1l 3.69
Transcriptomic analysis of LSD1 3.69
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.68
LIN28A Over-expression RNAseq 3.68
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.67
Loss of CREBBP results in gene expression repression in lymphoma cells 3.67
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 3.66
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 3.65
mRNA expression profile of Lymphocytes 3.64
Lysine benzoylation is a novel histone mark 3.64
Lysine benzoylation is a novel histone mark [RNA-seq] 3.64
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 3.62
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 3.62
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 3.62
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 3.6
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 3.58
RNA sequencing of primary human platelets and in vitro cell lines 3.51
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 3.49
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 3.48
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 3.43
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.4
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 3.4
Gene expression profiling of leukemia cells following asparagine depletion 3.39
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 3.38
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 3.36
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 3.33
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 3.33
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 3.33
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 3.33
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 3.3
Generating Patterned Kidney Organoids for Studying Development and Diseases 3.3
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 3.29
MYCL and EP400 are required for Max and MCPyV mediated gene activation 3.29
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.28
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 3.28
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 3.27
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 3.21
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 3.21
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.19
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 3.19
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 3.15
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 3.14
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 3.14
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 3.14
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 3.13
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 3.13
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 3.11
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 3.11
Effect of drugs on transcriptomic profiles 3.09
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 3.07
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 3.07
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 3.06
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 3.05
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 3.05
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 3.05
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 3.04
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 3.03
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 3.02
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 3.01
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 2.98
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 2.95
Illumina Total RNA-seq in HeLa 2.92
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 2.88
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.87
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.85
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 2.81
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 2.8
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.8
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 2.79
Genome-wide analysis of the Integrator complex (HTS) 2.79
Genome-wide analysis of the Integrator complex 2.79
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 2.73
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 2.73
Human Treg IL-12 stimulation 2.7
Systematic discovery of endogenous human ribonucleoprotein complexes 2.69
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 2.68
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 2.67
Stem and effector CD8 T-cells from human cancers 2.67
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.64
Primate-specific gene TMEM14B promotes cortical expansion and folding 2.64
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.63
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 2.6
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 2.56
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.54
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 2.53
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 2.52
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 2.5
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 2.5
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 2.49
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 2.48
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 2.47
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 2.47
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 2.44
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 2.43
Regulation of hypoxia-inducible factor activity by ZMYND8 2.41
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.41
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 2.4
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 2.4
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 2.38
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 2.35
Single-Cell Genotyping of Transcriptomes 2.35
RNA-seq of Single-Cell Genotyping of Transcriptomes 2.35
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 2.35
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 2.34
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 2.34
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 2.34
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 2.34
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 2.33
SLIGRL-induced gene expression changes in NHEK cells 2.31
Gene expression profile of multiple myeloma cell lines treated with CB-5083 2.31
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 2.31
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 2.27
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.24
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 2.24
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 2.23
Role of FGFR1 in neuronal devlopment 2.17
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 2.14
HNRNPM-regulated splicing dependencies in prostate cancer 2.14
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 2.1
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.08
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 2.07
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.06
RNA editing in nascent RNA affects pre-mRNA splicing 2.02
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 1.95
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 1.92
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 1.91
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 1.91
KSDM1b Role in Ewing Sarcoma 1.87
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.85
SOX11 knockdown in B-ALL cell lines 1.84
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 1.8
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.77
Global response to chemotherapy-induced apoptosis 1.77
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 1.71
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.68
RNA-Seq from human ILC transitional populations 1.66
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.66
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 1.64
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 1.63
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 1.63
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.6
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 1.59
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 1.57
BASP1 modifies the Tamoxifen response 1.52
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 1.51
Ribosomal protein RPL26 is the principal target of UFMylation 1.51
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.51
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.51
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.5
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.45
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.44
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.43
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.43
SLAM-seq for K562 endogenous mRNA decay 1.4
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 1.39
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 1.32
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 1.32
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 1.32
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.31
Human Treg IFNg/IL-10 subpopulations 1.29
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 1.28
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 1.28
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 1.27
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.26
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.21
RNA-seq data 1.2
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 1.2
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 1.18
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 1.17
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.14
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.13
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.12
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.1
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.1
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.1
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.1
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.09
The cytokine environment influence on human skin-derived T cells 1.09
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 1.09
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.05
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.04
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 1.03
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 1.03
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 1.02
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.01
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.98
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  0.97
Functional significance of the HIV-1 Tat signature amino acid residues 0.95
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.91
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.91
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.91
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.89
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 0.89
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.87
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.84
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.81
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.81
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 0.79
Gene profiling of human adult and pediatric liver cancer cells 0.72
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 0.72
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 0.72
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 0.7
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.68
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.66
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.65
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 0.64
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.62
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.61
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.59
An optimization system for isolating and sequencing of single human colon cancer cells 0.58
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.58
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 0.56
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 0.56
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.55
SNHG5 siRNA knock down in HCT116 cells 0.54
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 0.54
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 0.53
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.52
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.5
Efficient derivation of microglia-like cells from human pluripotent stem cells 0.42
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.42
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.42
The contribution of Alu exons to the human proteome 0.41
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.41
Transcriptome-wide modulation of splicing by the exon junction complex 0.39
Dermal endothelial cells of type 2 diabetic patients 0.37
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.37
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 0.36
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.36
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.36
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.35
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.31
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.3
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.3
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.3
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.27
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.26
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.26
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.25
Identification of a LIF-responsive replication-competent human β cell 0.22
FOXP1 orchestration of ASD-relevant signaling pathways. 0.22
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 0.2
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.2
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.17
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.16
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 0.15
RNA-Seq of the corpus callosum from 12 individuals 0.14
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.14
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.14
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.13
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.12
Global transcriptome analysis of WT versus HEB-/- hESCs 0.11
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.07
Transcriptional landscape changes during human embryonic stem cell derivation 0.04
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 0.03
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.03
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation